Melanoma Bridge 2023
A

Major Emerging Paradigm Shifts That Will Change Melanoma Management in the Coming 5 Years

By Melanoma Bridge 2023 FEATURING Alexander Eggermont
By Melanoma Bridge 2023 FEATURING Alexander Eggermont
289 views
January 8, 2024
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
20:09
Melanoma 2024: 34th Annual Cutaneous Malignancy Update

Dysplastic Nevi: Navigating the Risk Landscape

Feat. B. Kelley
23:16
Melanoma 2023: 33rd Annual Cutaneous Malignancy Update

2023 Updates on Dysplastic Nevi

Feat. B. Kelley
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
12:46
Stanford Medicine

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Feat. A. Betof Warner
09:00
AAD 2024 Insights

AAD 2024 Insights: What's New In Nail Tumors

Feat. J. Dominguez-Cherit
13:47
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Expanding the Benefit - Dabrafenib/Tramet…

Feat. V. Subbiah
23:09
Total Health

Key Updates in Skin Melanoma

Feat. R. Seedor
10:39
University of Colorado Department of Medicine

Cardio-Oncology: Definitions and Scope

Feat. L. Kondapalli
06:39
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Final Analysis of Distant Metastasis-Free…

Feat. J. Luke
24:14
Masterclasses in Dermatology

Advances in the Treatment of Melanoma

Feat. D. Fisher
08:48
David Polsky

Promoting Skin Self-Exam for the Secondary Prevention of Melanoma

25:44
Melanoma 2024: 34th Annual Cutaneous Malignancy Update

Melanoma in the Molecular Age - Part 1: New Tools for Diagnosis, Pro…

Feat. G. Hosler
18:21
Vanderbilt University Medical Center (VUMC)

NCCN Guidelines Updates for the Management of Cutaneous Melanoma: Ne…

Feat. D. Johnson
05:20
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Impact of Immune Checkpoint Inhibition on…

Feat. E. Buchbinder
19:52
OncoAlert

Melanoma Updates: Adjuvant Therapy, Advanced Disease, Uveal Melanoma…

Feat. A. Betof Warner
08:38
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Phase 3 Trial Comparing Fianlimab + Cem…

Feat. T. Panella
52:19
Winship Melanoma and Cutaneous Oncology Symposium

2024 Updates on Neoadjuvant Therapy for Resectable Melanoma

Feat. S. Patel
21:04
Penn Medicine Abramson Cancer Center

Pediatric Melanoma

Feat. M. Jen
05:37
Melanoma Bridge 2023

COLUMBUS 7-Year Update: Encorafenib + Binimetinib vs. Vemurafenib or…

Feat. R. Dummer
21:12
Robert Swerlick

Dealing With Melanoma Overdiagnosis: Can We Find an Off-Ramp?